Konstantinos Arnaoutakis, MD

Articles by Konstantinos Arnaoutakis, MD

Dr. Arnaoutakis on the ADAURA Trial Examining Osimertinib in EGFR-Mutant Lung Cancer

December 8th 2021

Konstantinos Arnaoutakis, MD, discusses the phase 3 ADAURA trial examining osimertinib in the adjuvant treatment of patients with EGFR-mutant lung cancer.

Latest Updated Articles

Trending on OncLive

FDA CTGTAC Votes in Favor of RP1/Nivolumab Data in Advanced Melanoma

FDA Grants Priority Review to Subcutaneous Amivantamab in Head and Neck Cancer

FDA Awards Orphan Drug Designation to Enzomenib for ALL

Dr Barot on the FDA Approval of Palbociclib/Trastuzumab ± Pertuzumab in HER2+ Breast Cancer

Dana-Farber Researchers Identify CDK8 as a Potential Therapeutic Target for Alveolar Rhabdomyosarcoma